ACIU (ACIU) Stock Price & Analysis
ACIU (ACIU) fell 2.39% to USD 2.86 as of September 8, 2026 at 06:55 UTC, according to Nexqual real-time market data.
ACIU last closed at USD 2.86; the session ranged USD 2.82–2.94 on volume of 155,628 shares. Market capitalization is —, with a 52-week range of USD 2.1–4 (NGM). Source: Nexqual, September 8, 2026 at 06:55 UTC.
Key Statistics (as of September 8, 2026 at 06:55 UTC)
| Price | USD 2.86 |
|---|---|
| Change | ▼ 2.39% (down) |
| Previous Close | USD 2.86 |
| Open | USD 2.86 |
| Day Range | USD 2.82 – 2.94 |
| 52-Week Range | USD 2.1 – 4 |
| Volume | 155,628 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (ACIU)
Nexqual's technical model rates ACIU "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 06:55 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 61.59 (neutral) |
| vs SMA50 | Above (USD 2.49) |
| MACD | 0.11 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CRVS | Corvus Pharmaceuticals, Inc. | USD 14.39 | ▲ 1.34% |
| CTMX | CytomX Therapeutics, Inc. | USD 3.71 | ▼ 0.27% |
| ACRS | Aclaris Therapeutics, Inc. | USD 6.17 | ▼ 0.16% |
| ALEC | Alector, Inc. | USD 2.46 | ▼ 9.56% |
| ADIL | Adial Pharmaceuticals, Inc | USD 7.12 | ▲ 12.66% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:55 UTC. This page is informational and not investment advice.